Tanezumab (RN624)

by | Jul 2, 2010 | Emerging Technology Report

An intravenous monoclonal antibody against nerve growth factor for relief of chronic osteoarthritis pain in the knee and hip.If you have a Hayes login, click here to view the full report on the Knowledge Center.